• Japanese
  • Korean
  • Chinese
Cover Image

Nanobiotechnology

Abstract

Description

This report analyzes the worldwide markets for Nanobiotechnology in US$ Million by the following Technology Segments: Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, & Other Nanomaterials), and Nanodevices/Tools. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players worldwide such as Aduro BioTech, Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Agilent Technologies Inc., Asklepios BioPharmaceutical Inc., Biosante Phosphate Pharmaceuticals, Inc., Celgene Corporation, Elan Pharmaceuticals, Elitech Group, Flamel Technologies, Inc., Gilead Sciences Inc., Life Technologies Corporation, NanoBio Corporation, Nanogen, Inc., Nanophase Technologies Corporation, pSivida Ltd., Sigma Aldrich Company, Starpharma Holdings Ltd., Dendritic Nanotechnologies, Inc., SkyePharma Pharmaceuticals, Unidym, Inc., and Zyvex Instruments LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • 1. Nanomaterials
      • Solid Inorganic Nanoparticles
      • Nanocomposites
      • Nanostructured Materials and Membranes
      • Nanotubes and Fullerenes
      • Other Nanomaterials
        • Nanoshells
        • Nanohorns
        • Nanocapsules
    • 2. Nanodevices/Tools

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Curtain Raiser
  • Nanobiotechnology - The Next Big Thing
  • Nanotechnology & Biology Tie the Knot: "Two to Tango"
  • Where Conventional Molecular Science Falls Short... Nanobio Steps In
  • What's The Obsession With Size?
  • Why Analysis at the Cellular Level is Important?
  • Lessons from Nature
  • Dawn Breaks On Nanobiotechnology
    • Table 1: Nanobiotechnology and Related Medical Applications Market (2007): Percentage Share Breakdown of Activity Distribution by Region and Organizational Set-Up (includes corresponding Graph/Chart)
    • Table 2: Percentage Breakdown of Number of Nanotechnology Companies in Healthcare Industry Worldwide by Region/Country (2008) (includes corresponding Graph/Chart)
    • Table 3: Percentage Breakdown of Number of Nanotechnology Companies in Healthcare Industry Worldwide by Type - Private and Public Sector (2008) (includes corresponding Graph/Chart)
    • Table 4: Percentage Breakdown of Number of Nanotechnology Companies in Healthcare Industry Worldwide By Sector - Therapeutics and Drug Delivery; Clinical Diagnostics; Drug Discovery Tools and Biomedical Research; and Biomaterials and Biomedical Implants (2008) (includes corresponding Graph/Chart)
    • Table 5: Percentage Breakdown of Number of Nanotechnology Companies in The field of Therapeutics and Drug Delivery Worldwide by Area - Targeted Nanoparticles, Solubility & Reformulation, Sustained Release, Blood Brain Barrier, Nanomaterial Therapeutics and Others (2008) (includes corresponding Graph/Chart)
    • Table 6: Percentage Breakdown of Number of Nanotechnology Companies in the field Therapeutics Worldwide by Therapeutic Area - Oncology, Infectious Diseases, Central Nervous System Diseases, Nutraceuticals, Ophthalmology and Others (2008) (includes corresponding Graph/Chart)
    • Table 7: Percentage Breakdown of Number of Nanotechnology Companies in the field of Clinical Imaging and Diagnostics Worldwide by Area - Tags and Probes; Imaging Agents; Biosensors and Bio-detection; and Instruments (2008) (includes corresponding Graph/Chart)
  • Demystifying the Intriguing World of Nanobiotech
  • A Meeting Place of Medicine's Best Solutions
  • Nanobiotechnology Promises to Deliver Nanomedicine
  • Nanobiotechnology to Become Viable for All Drug Development Stages
    • Nanobioproducts in R&D As of 2007 & 2008
    • List of Marketed Nanoparticle-Based Pharmaceutical Products As of the Year 2007
  • Nanoparticles: The Foundation of Nanobiotechnology
  • Improved Optical Properties and Stability of Nanoparticles
  • Nanoemulsions
  • Diagnosis & Treatment of Cancer
  • The Promise of Nanobiotechnology
  • Biological Weaponries Against Diseases Come in Small Packages
  • Proffered Benefits of Nanobiotechnology
  • Opportunity & Beyond
  • Nanobiotechnology - Will it Live Up to the Expectations?
  • The Future of Nanobiotechnology: Shape of Things to Come
  • Nanobiotechnology: The Outer Limits
  • Futuristics: A Rumination
  • Nanobiotechnology In the Year 2015
    • Field of Nanodiagnostics
    • Field of Regenerative Medicine
    • Field of Targeted Drug Delivery
  • Conclusions

2. MARKET DYNAMICS

  • Nanotechnology & the 2007-2009 Recession: A Review
  • Nanobio Feels the Pinch or Does It...? : A Closer Look
  • Will Growth in Europe Be Held Hostage by the Debt Crisis?
  • Outlook
  • Developing Countries to Rise Over the Horizon
    • Table 8: Global Nanobiotechnology Market (2007): Percentage Share Breakdown of Investments by Region (includes corresponding Graph/Chart)
    • Table 9: Worldwide Funding in Nanotechnology (2004 & 2009): Percentage Breakdown of Value Investments by Country/Region: A Comparison (includes corresponding Graph/Chart)
  • Nanomaterials & Nanoparticles Witness Robust Activity
  • Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
  • Private & Public Companies to Step Up Funding on Nanotechnology
    • Table 10: Worldwide Government Funding in Nanotechnology (2008-2015) (In US$ Billion) (includes corresponding Graph/Chart)
  • Increasing Awareness on Technology to Drive Growth
  • Demand for Novel Products to Push Up Growth
  • Nano-Enabled Drug Discovery Holds Tremendous Potential
  • Consolidation Sharpens the Industry's Edge
  • The Regulatory Framework Evolves with the Technology
  • Quantum Dot Patents Pose Legal Tangles
  • Miniaturized Liquid Handling Becomes Progressive
  • Trends in Nanotechnology Enabled Drug Delivery Systems
  • Robust Growth On Cards
    • Table 11: Global Nanotechnology-Enabled Drug Delivery Systems Market (2015 (P)): Percentage Share Breakdown of Nanoparticles, Dendrimers, Polymer Therapeutics and Other Nanostructures (includes corresponding Graph/Chart)
  • Patent Expiries: A Key Driver
  • Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs

3. INDUSTRY CHALLENGES & ISSUES

  • Challenges
  • Commercial Exploration: A Treacherous Voyage
  • Conventional Medicine to Contest Nanomedicine Adoption
  • Nanomaterials Use: Weighed Down with Toxicity Concerns
  • Production Issues Continue to Plague Nanobiotech Industry
  • Lack of De Facto Standards: A Challenge to Reckon With
  • Embroilment Over Ethical Issues
  • Social Relevance
  • Economic Relevance

4. INDUSTRY STRUCTURE

  • Industry Structure: A Quick Primer
  • A Dissection of Select Segments
    • Nanoparticles
    • Nanotubes and Fullerenes
    • Dendrimers
  • A Peek Into the Regulatory Framework
  • United States
  • Europe
  • A Closer Look at Regional Nano Efforts
  • United States: Unraveling the Country's Edge
    • Table 12: Global Intellectual Property Rights in Nanotechnology by Leading Countries (2007) (includes corresponding Graph/Chart)
  • Europe: Hot On the Heels of the US
    • Germany
    • France
    • United Kingdom
    • Scandinavia
  • Japan: A Noteworthy Region

5. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE

  • A Primer
  • Impact on Drug Delivery Systems
  • Benefits Offered
    • Drug Encapsulation
    • High Level of Specificity
    • Increase in Drug Solubility and Uptake
    • Greater Usage Flexibility
  • Impact On Molecular Diagnostic Imaging
  • Seeing The Unseen
  • Impact On Pharmaceutical Drug Formulations
  • Impact On Therapeutics
  • Silver Nanoparticles as Effective Antimicrobial Agents
  • Modern Day Nanomedicine: A Current Scenario
  • Nanomedicine: The Cynosure of All Eyes
    • Drug Delivery Systems Epitomized by Nanomedicine
      • Targeted NanoDrug Delivery & Release
      • Active and Passive Targeting Mechanisms in Drug Delivery
      • Sustained and Pulsatile Release Mechanisms in Drug Delivery
      • A Peek Into Potential Nanobio Enabled Drug Carriers
      • Micelles
      • Liposomes
      • Dendrimers & Liquid Crystals
      • Nanoparticles
      • Polymeric Nanoparticles
      • Hydrogels
      • Molecularly Imprinted Polymers
      • Microelectromechanical Systems (MEMS)
      • Nanosuspensions
      • Fullerenes: A Platform for GenX Drug Delivery
      • Types of Nano-Based Drug Delivery Systems, Related Materials, and Structures
    • Dynamics of Regenerative Medicine
      • Tissue Engineering and Restorations
  • Nanotechnology Enabled Diagnostics
    • Promised Path Breaking Applications in Molecular Diagnostics & Imaging
      • In-Vitro Diagnostics
      • Nanoprobes & Implantable Devices in In-vivo Imaging
      • Nanocomposites in Molecular Labeling & Diagnostics
      • Laboratory-on-a-Chip - A Revolutionary Technology in Biomolecular Detection
      • Biosensors - Heralding New Opportunities in Molecular Diagnostics
      • Nanobiosensors - A New Approach to Diagnostics Testing
      • Despite Huge Potential ... Key Hurdles Remain in Commercialization
      • Magnetic Nanoparticles for Imaging Applications in MRI
      • Dendrimers Promise Milestone Applications in MRI
  • Conclusions
  • Gauging the Real World Impact of Nanobiotech On Cancer: A Case Study
  • Quantum Dots Cock a Snook at Traditional Anti-Body Labeling Agents
  • Chemotherapeutic Reengineering & Gene Therapy: New Treatment Regimes
  • Laboratory-on-chip (LOC): A Platform for Cancer Diagnosis

6. CONCEPTUAL OVERVIEW

  • Nanotechnology: An Introduction
  • A Revolution in the Making
  • Nanobiotechnology: An Exposition
  • Nanobiotechnology & Medicine
  • Nanobiotechnology & Biofuels
  • Global Nanobiotechnology Market (2005): Major Products
  • Global Nanobiotechnology Market (2005): Major Products Under Development
  • Analysis of Major Technology Segments
  • Nanomaterials
    • Nanoparticles
      • Nanoparticles in Labeling or Bio Tagging
      • Nanoparticles as Biomarkers
      • Classification of Nanoparticles
      • Solid Nanoparticles
      • Solid Lipid Nanoparticles
      • Calcium Phosphate Nanoparticles
      • Dendrimers
    • Nanocomposites
      • Lamellar Nanocomposites
    • Nanostructured Materials and Membranes
    • Nanotubes and Fullerenes
    • Other Nanomaterials
      • Nanoshells
      • Nanohorns
      • Nanocapsules
  • Nanodevices
  • Nanotools
    • Select Nanotools
      • Atomic Force Microscopes
      • Hot Embossing Lithography
      • Dip-Pen Nanolithography

7. GLOBAL RESEARCH CENTERS AND INSTITUTIONS

  • Centre for Biologic Nanotechnology (USA)
  • Centre for Biological and Environmental Nanotechnology (USA)
  • Institute of Bioengineering and Nanotechnology (Singapore)
  • The Nanobiotechnology Center (USA)
  • The Tyndall National Institute (Ireland)

8. STRATEGIC CORPORATE DEVELOPMENTS

  • Agilent Acquires BIOCIUS
  • IDEX Inks Deal to Acquire Microfluidics
  • NanoMech Takes Over Canano
  • Arrowhead Sells Unidym to Wisepower
  • MP Biomedicals Signs Agreement of Cooperation with Russian Nanotechnology Corporation
  • Bruker Acquires AFM and OIM Segments from Veeco
  • Audax Inks an Agreement with Brown to Acquire Osteobiologic Nanotechnology
  • Celgene Acquires Abraxis
  • ELITech Completes Assets Acquisition of Nanogen
  • Life Technologies Acquires BioTrove
  • GSK Inks License With NanoBio to Market NB-001
  • CPN Establishes New Medical Nanobiotechnology R&D Center
  • IBM to Setup New Research Center in Wroclaw
  • Life Technologies and Zymera Ink Licensing Deal for Quantum Dots Technology
  • APR Acquires Nanotechnology Platform Technology for Preparing Biotechnology Products
  • Lockheed Teams Up with IIT-Delhi for Nanobiotechnology Research
  • Piedmont Triad to Institute Statewide Nanobiotech Center

9. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER

  • Biocon and Abraxis Introduce ABRAXANE in India
  • Starpharma Launches a Research Reagent Kit
  • Monash Enters Into a Deal with National Fabrication Facility of Australia
  • Taiwan Inks Nanotechnology Collaboration Deal with Australia
  • Avanti Institutes New Targeted Drug Delivery Company, Chikujee Therapeutics
  • CytoViva Rolls Out New Research Tool for Nanotechnology
  • Dabur Obtains DCGI Approval for Nanoxel in New Indications
  • Researchers Discover New Nanoparticles for Treating Brain Infection
  • Capsulution Tests Nanoparticle-Based Drug Formulation for Improved Bio-Availability
  • Invitrogen Signs Agreement with Genisphere
  • Sigma-Aldrich Signs Deal With Nanoco Technologies
  • Unidym Sells First License Option for Patent Portfolio to MDA
  • Unidym Spins Off Carbon Nanotubes Therapeutics Business into Ensysce Biosciences
  • Nacalai USA and Nano-C Enter into Collaboration Agreement for HPLC Technology
  • Advanced Materials Technology Obtains License for LBL® Technology from Capsulution
  • Nanogen and The Elitech Group Announce Merger
  • NanoViricides Signs MCRADA Agreement with CDC for Rabies
  • Manhattan Scientifics Acquires Metallicum
  • HemCon Medical Technologies Acquires Alltracel Pharmaceuticals
  • CN Probes Inks Agreement With a Leading MEMS Foundry
  • PrimeGen Biotech LLC Enters into Corporate Alliance with Unidym
  • Ondine Acquires Exclusive License from UCL Business
  • Dabur Introduces Nanotechnology Based Anti-Cancer Drug Delivery System - Nanoxel
  • Mitsui Ties Up With NIOSH to Evaluate Safety of Carbon Nanotubes
  • Unidym Merges with Carbon Nanotechnologies

10. FOCUS ON SELECT GLOBAL PLAYERS

  • Aduro BioTech (USA)
  • Arrowhead Research Corporation (USA)
  • Calando Pharmaceuticals, Inc. (USA)
  • Agilent Technologies Inc (USA)
  • Asklepios BioPharmaceutical Inc (USA)
  • Biosante Phosphate Pharmaceuticals, Inc. (USA)
  • Celgene Corporation (USA)
  • Elan Pharmaceuticals, Inc. (USA)
  • Elitech Group (France)
  • Flamel Technologies, Inc. (France)
  • Gilead Sciences Inc (USA)
  • Life Technologies Corporation (USA)
  • NanoBio Corporation (USA)
  • Nanophase Technologies Corporation (USA)
  • pSivida Ltd (Australia)
  • Sigma Aldrich Company (USA)
  • Starpharma Holdings Ltd. (Australia)
  • Dendritic Nanotechnologies, Inc. (USA)
  • SkyePharma Pharmaceuticals (UK)
  • Unidym, Inc. (USA)
  • Zyvex Instruments LLC (USA)

11. GLOBAL MARKET PERSPECTIVE

    • Table 13: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 15: World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
  • Analytics by Product Segment
    • Table 16: World Recent Past, Current & Future Analysis for Nanomaterials by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Nanomaterials by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 18: World 15-Year Perspective for Nanomaterials by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 19: World Recent Past, Current & Future Analysis for Solid Inorganic Nanoparticles by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Solid Inorganic Nanoparticles by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 21: World 15-Year Perspective for Solid Inorganic Nanoparticles by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 22: World Recent Past, Current & Future Analysis for Nanocomposites by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Nanocomposites by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 24: World 15-Year Perspective for Nanocomposites by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 25: World Recent Past, Current & Future Analysis for Nanostructured Materials & Membranes by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Nanostructured Materials & Membranes by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 27: World 15-Year Perspective for Nanostructured Materials & Membranes by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Nanotubes and Fullerenes by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Nanotubes and Fullerenes by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 30: World 15-Year Perspective for Nanotubes and Fullerenes by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Other Nanomaterials by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Other Nanomaterials by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 33: World 15-Year Perspective for Other Nanomaterials by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Nanodevices/Tools by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Nanodevices/Tools by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 36: World 15-Year Perspective for Nanodevices/Tools by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
  • Analytics by Application
    • Table 37: World Recent Past, Current & Future Analysis for Nanobiotechnology by Application - Pharmaceuticals, Medical Devices, Medical Research and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2017 (includes corresponding Graph/Chart)
    • Table 38: World 10-Year Perspective for Nanobiotechnology by Application - Percentage Breakdown of Revenues for Pharmaceuticals, Medical Devices, Medical Research and Others for Years 2008, 2011 & 2017 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Industry Overview
    • Public Sector Funding
    • Major Nanobiotechnology Institutions and Centers
      • The Nanobiotechnology Center (NBTC)
      • Key technological advances achieved by NBTC in recent years -
      • Principal NBTC Partners
      • Centre for Biologic Nanotechnology (CBN)
      • Centre for Biological and Environmental Nanotechnology (CBEN)
    • Regulatory Environment
  • B. Market Analytics
    • Table 39: US Recent Past, Current & Future Analysis for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 40: US Historic Review for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 41: US 15-Year Perspective for Nanobiotechnology by Technology Segment -Percentage Breakdown of Revenues for Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

2. JAPAN

  • A. Market Analysis
    • Public Sector Funding
  • B. Market Analytics
    • Table 42: Japanese Recent Past, Current & Future Analysis for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 43: Japanese Historic Review for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 44: Japanese 15-Year Perspective for Nanobiotechnology by Technology Segment - Percentage Breakdown of Revenues for Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Market Overview
      • European Union Banks Heavily on Nanobiotechnology
      • Nano2Life Network
      • Major Nanobiotechnology Networks in Europe as of the Year 2006
    • Public Sector Funding
    • Regulatory Environment
    • Registration for Novel Nanobiotech Drugs Pose Major Bottlenecks
    • Focus on Select Markets
      • Germany
      • France
      • United Kingdom
      • Russia
      • Russian Biotech Players Eye Partnerships with Indian Counterparts
      • Rest of Europe
      • Ireland
      • Market Overview
      • Key Research Institutions/Centers in Nanobiotechnology
      • The Tyndall National Institute
      • The Centre for Research on Adaptive Nanostructures and NanoDevices
      • The National Centre for Sensor Research
      • The Sami Nasr Institute for Advanced Materials Science
  • B. Market Analytics
    • Table 45: European Recent Past, Current & Future Analysis for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 46: European Historic Review for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 47: European 15-Year Perspective for Nanobiotechnology by Technology Segment - Percentage Breakdown of Revenues for Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools for Years 2003 2011 & 2017 (includes corresponding Graph/Chart)

4. REST OF WORLD

  • A. Market Analysis
    • Public Sector Funding
    • Focus on Select Markets
      • Australia
      • Market Overview
      • Major Institutions
      • Commonwealth Scientific and Industrial Research Organisation (CSIRO)
      • India
      • Market Overview
      • Government Takes Big Initiatives to Promote Nanobiotechnology
      • Agriculture, Livestock Sectors to Warm Up to Nanobiotechnology Benefits
      • Korea
      • Taiwan
      • Nanotechnology in Medicine - Small Yet Growing Segment in Taiwan
      • Iran
  • B. Market Analytics
    • Table 48: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 49: Rest of World Historic Review for Nanobiotechnology by Technology Segment - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 50: Rest of World 15-Year Perspective for Nanobiotechnology by Technology Segment - Percentage Breakdown of Revenues for Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, Other Nanomaterials) and Nanodevices/Tools for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing
Get Notified
Email me when related reports are published